NASDAQ · BNR
Burning Rock Biotech Limited financials
$18.94+7.43%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 | Q4 '20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — |
| Diluted shares | 106.3M | 102.9M | 102.4M | 103.9M | 10.4M | 51.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $68.4M | $71.2M | $86.9M | $131.3M | $224.6M | $290.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $10.0M | $55.5M |
| Total debt | $271.6K | $0.00 | $0.00 | $0.00 | $372.0K | $7.2M |
| Total assets | $117.3M | $121.3M | $146.9M | $230.1M | $357.6M | $408.1M |
| Total liabilities | $40.8M | $41.7M | $38.4M | $62.2M | $68.0M | $37.1M |
| Shareholders' equity | $76.5M | $79.6M | $108.6M | $167.9M | $289.6M | $371.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology